Japan Artificial Pancreas Device System Market Insight
Published: 02 June 2026 | Report Format: Electronic (PDF)
The Japan market for artificial pancreas devices system is growing at a CAGR of 15.09%. The reasons behind this market growth include higher prevalence of diabetes cases, increasing use of automated insulin delivery systems, and increased demand for continuous glucose monitoring (CGM) devices.
Japan Artificial Pancreas Device System Market Insights Forecasts to 2035
- The Japan Artificial Pancreas Device System Market Size Was Estimated at USD 150.34 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 15.09 % from 2025 to 2035
- The Japan Artificial Pancreas Device System Market Size is Expected to Reach USD 612.87 Million by 2035
Notable Insights for Japan Artificial Pancreas Device System Market
- According to the type of device, threshold suspend device system segment held around 41-43% of the Japan artificial pancreas device system market share in 2025 as an increased use of automated insulin suspension devices for hypoglycemia prevention has been witnessed.
- According to end user, home healthcare sector was found to account for around 58-60% of the Japan artificial pancreas device system market in 2025 due to growing usage of wearable diabetes management and remote glucose monitoring devices.
- Aging demographics and growing cases of diabetes are driving the demand for AI-driven insulin delivery systems, smart continuous glucose monitors (CGM), and other diabetic monitoring technologies.
- The presence of attractive investment opportunities related to closed loop insulin systems, wearable medical technologies, AI-based diabetic analytics platforms, and remote patient monitoring solutions is anticipated to benefit players in Japan's market.
Download the eBook (ToC)
Why Buy This Report
- Gain comprehensive insights into the Japan artificial pancreas device system market, including market size, growth trends, competitive landscape, and future forecast analysis driving the diabetes care and medical device industry.
- Analyze increasing demand for automated insulin delivery systems, continuous glucose monitoring devices, smart insulin pumps, wearable diabetes technologies, and AI-powered glucose management platforms across Japan.
- Identify high-growth investment opportunities through detailed evaluation of diabetes technology trends, wearable healthcare developments, AI-powered patient monitoring innovations, and strategic healthcare digitalization initiatives shaping the Japan artificial pancreas device system market.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the Japan Artificial Pancreas Device System market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment Market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the Market.
Top Companies in Japan Artificial Pancreas Device System Market
- Medtronic plc
- DexCom, Inc.
- Insulet Corporation
- Tandem Diabetes Care, Inc.
- Abbott Laboratories
- F. Hoffmann-La Roche Ltd.
- Ypsomed AG
- Senseonics Holdings, Inc.
- Terumo Corporation
- Sanofi S.A.
- Other
Recent Developments:
- In February 2026, diabetes device manufacturers accelerated investments in AI-powered glucose prediction systems and automated insulin delivery technologies to improve glycemic control and patient safety.
Market Segmentation:
Japan Artificial Pancreas Device System Market, By Device Type
- Threshold Suspend Device Systems
- Control-to-Range Systems
- Control-to-Target Systems
Japan Artificial Pancreas Device System Market, By Component
- Continuous Glucose Monitoring Systems
- Insulin Pumps
- Control Algorithms
- Others
Japan Artificial Pancreas Device System Market, By End User
- Hospitals
- Clinics
- Home Healthcare Settings
- Others
Expert Views:
The Japan artificial pancreas device system market is likely see pretty substantial growth in the coming years, mainly because diabetes is becoming more common, people are starting to use wearable healthcare tech more often, and there is also a steady rise in investments around AI powered diabetes management systems. Over time, improvements in continuous glucose monitoring technologies, automated insulin delivery platforms, predictive glucose analytics systems, plus smart wearable medical devices are expected to push market growth forward across Japan. Also, more spending in digital healthcare ecosystems, remote patient monitoring infrastructure, and smarter diabetes care technologies should give a lot of chances for market players working in the Japan artificial pancreas device system industry.
Author: Aditi and Govind By Spherical Insights and Consulting